For HER2+ subtype, we identified cancer cells, proliferating cancer cells, T cells, B cells, endothelial cells, plasma, pericytes, tumour‐associated macrophages (TAMs), cancer‐associated fibroblasts (CAFs) (Figure 1E) based on the marker genes (Figure 1H). Here, ERBB2 is linked to neoplasm.